Inventor
EMILY RIGSBEE
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
C07BGeneral methods of organic chemistry23%
C07DHeterocyclic compounds23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for5%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation5%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
12,492,206Salts of R-ketorolac202512,297,177Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof202512,116,347Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof202412,090,137Solid D202411,905,255Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof202411,884,635Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof202411,884,634Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide202411,845,732Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof202311,820,748Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof202311,787,819Crystalline salt of a multi-tyrosine kinase inhibitor, method of preparation, and use thereof202311,566,006Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof202311,478,447Solid D2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to CANNA CHEMISTRIES LLC (2)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to PFIZER (8)· patent assignee history
2023Patents assigned to MIRATI THERAPEPEUTICS INC (1)· patent assignee history
2023Patents assigned to MIRATI THERAPEUTICS INC (1)· patent assignee history
2025Patents assigned to UNM RAINFOREST INNOVATIONS (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PFIZER | 8 | 2023–2025 |
| CANNA CHEMISTRIES LLC | 2 | 2022–2024 |
| MIRATI THERAPEPEUTICS INC | 1 | 2023 |
| MIRATI THERAPEUTICS INC | 1 | 2023 |
| UNM RAINFOREST INNOVATIONS | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2022–2025 |